|
ELF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.867500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.914400E-01 |
| Normal-vs-Stage2 |
1.794220E-01 |
| Normal-vs-Stage3 |
5.917100E-03 |
| Normal-vs-Stage4 |
2.696600E-01 |
| Stage1-vs-Stage2 |
1.862370E-01 |
| Stage1-vs-Stage3 |
5.721300E-03 |
| Stage1-vs-Stage4 |
2.808400E-01 |
| Stage2-vs-Stage3 |
4.928600E-01 |
| Stage2-vs-Stage4 |
9.299400E-01 |
| Stage3-vs-Stage4 |
4.765000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.420600E-01 |
| Normal-vs-AfricanAmerican |
6.916000E-02 |
| Normal-vs-Asian |
8.234000E-02 |
| Caucasian-vs-AfricanAmerican |
2.493400E-01 |
| Caucasian-vs-Asian |
4.512000E-02 |
| AfricanAmerican-vs-Asian |
2.298800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.985800E-01 |
| Normal-vs-Female |
3.840500E-03 |
| Male-vs-Female |
1.217770E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.532400E-01 |
| Normal-vs-Extreme_Weight |
9.419200E-01 |
| Normal-vs-Obese |
1.907810E-02 |
| Normal-vs-Extreme_Obese |
9.641700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.597800E-01 |
| Normal_Weight-vs-Obese |
1.914040E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.382100E-02 |
| Extreme_Weight-vs-Obese |
1.670060E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.511610E-01 |
| Obese-vs-Extreme_Obese |
1.817640E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.595510E-02 |
| Normal-vs-Age(41-60Yrs) |
3.246500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.356400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.366400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.668200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.258200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.564000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.163000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.929000E-01 |
| Normal-VS-Type2 PRCC |
2.751000E-01 |
| Normal-VS-KIRP CIMP |
3.425800E-04 |
| Normal-VS-Unclassified PRCC |
3.768400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.301200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.02811117794499E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.128300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.990200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.834400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.55367999999934E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.658800E-01 |
| Normal-vs-N1 |
2.123900E-03 |
| Normal-vs-N2 |
7.336200E-02 |
| N0-vs-N1 |
5.322600E-03 |
| N0-vs-N2 |
6.236800E-03 |
| N1-vs-N2 |
6.250200E-01 |
|
|
